reference/765081

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/765081

Outgoing Links

Predicate	Object
contentType	Case Reports\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	527
issn	0021-9738
issueIdentifier	2
pageRange	520-527
publicationName	The Journal of clinical investigation
startingPage	520
bibliographicCitation	Baggio G, Manzato E, Gabelli C, Fellin R, Martini S, Enzi GB, Verlato F, Baiocchi MR, Sprecher DL, Kashyap ML. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest. 1986 Feb;77(2):520–7. PMID: 3944267; PMCID: PMC423374.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db26bca0f5d9e87a7677385459ea8bd7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3acbb4ae1fd81000ca24f946852a983b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c43eb4f7c90c6443e4f7e09630eb6cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25524e68c9acde46a765ea37cc09394b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_854e20ac1502587aafb69f89943c884a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3927575e51a242b4978182da97e5518 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92e0cb108e7a19e7dfb4548210c5fae5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_050ef56d7fd473c6d997fe1b90c54931 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_921c45678fdf8223dcf08dc9c7662a9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c258fe91d3cb0b81b8379274000cc243
date	1986-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/3944267 https://pubmed.ncbi.nlm.nih.gov/PMC423374 https://doi.org/10.1172/jci112332
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4632 https://portal.issn.org/resource/ISSN/0021-9738
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
discusses	http://id.nlm.nih.gov/mesh/M0012596 http://id.nlm.nih.gov/mesh/M0021969 http://id.nlm.nih.gov/mesh/M0001599 http://id.nlm.nih.gov/mesh/M0012584 http://id.nlm.nih.gov/mesh/M0012590 http://id.nlm.nih.gov/mesh/M0004455 http://id.nlm.nih.gov/mesh/M0066119 http://id.nlm.nih.gov/mesh/M0012545 http://id.nlm.nih.gov/mesh/M0012581
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008074Q000097 http://id.nlm.nih.gov/mesh/D001056Q000172 http://id.nlm.nih.gov/mesh/D008049Q000097 http://id.nlm.nih.gov/mesh/D014280Q000097
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014644 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001056Q000235 http://id.nlm.nih.gov/mesh/D008077Q000097 http://id.nlm.nih.gov/mesh/D008075Q000097 http://id.nlm.nih.gov/mesh/D001056Q000627 http://id.nlm.nih.gov/mesh/D008079Q000097 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D002914Q000097 http://id.nlm.nih.gov/mesh/D053304
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9772 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_42da9f284e171ed590b34ccde98bc7e4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10895 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8340 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9650 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_114dde61ee8708c9c30c287ea2b919e1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9683 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460048 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8768

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID292697 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID344

Total number of triples: 64.